158 related articles for article (PubMed ID: 48349)
21. Antithyroid drugs.
Cooper DS
N Engl J Med; 2005 Mar; 352(9):905-17. PubMed ID: 15745981
[No Abstract] [Full Text] [Related]
22. Propylthiouracil for hyperthyroidism.
Med Lett Drugs Ther; 2009 Jul; 51(1317):57. PubMed ID: 19636289
[No Abstract] [Full Text] [Related]
23. Drug resistant-Mycobacterium leprae--results of mouse footpad studies from a laboratory in south India.
Ebenezer GJ; Norman G; Joseph GA; Daniel S; Job CK
Indian J Lepr; 2002; 74(4):301-12. PubMed ID: 12624978
[TBL] [Abstract][Full Text] [Related]
24. Screening of drugs for activity against Mycobacterium leprae.
Baohong J; Matsuo Y; Colston MJ
Int J Lepr Other Mycobact Dis; 1987 Dec; 55(4 Suppl):836-42. PubMed ID: 3325576
[No Abstract] [Full Text] [Related]
25. Multidrug resistant Mycobacterium leprae from patients with leprosy.
Maeda S; Matsuoka M; Nakata N; Kai M; Maeda Y; Hashimoto K; Kimura H; Kobayashi K; Kashiwabara Y
Antimicrob Agents Chemother; 2001 Dec; 45(12):3635-9. PubMed ID: 11709358
[TBL] [Abstract][Full Text] [Related]
26. Combinations of drugs against Mycobacterium leprae studied in mice.
Shepard CC
Int J Lepr Other Mycobact Dis; 1972; 40(1):33-9. PubMed ID: 4562383
[No Abstract] [Full Text] [Related]
27. Prospects for chemotherapy of leprosy.
Ji B
Indian J Lepr; 2000; 72(2):187-98. PubMed ID: 11008659
[No Abstract] [Full Text] [Related]
28. Progress in the chemotherapy of leprosy.
Grosset JH
Int J Lepr Other Mycobact Dis; 1994 Jun; 62(2):268-77. PubMed ID: 8046266
[No Abstract] [Full Text] [Related]
29. Dormancy, drug resistance or dependency; some thoughts to ponder.
Shetty VP; Mistry NF; Uplekar MW; Antia NH; Pai VV; Ganapati R
Int J Lepr Other Mycobact Dis; 1996 Dec; 64(4):455-7. PubMed ID: 9030116
[No Abstract] [Full Text] [Related]
30. Antithyroid drugs in practice.
Vanderlaan WP
Mayo Clin Proc; 1972 Dec; 47(12):962-5. PubMed ID: 4117991
[No Abstract] [Full Text] [Related]
31. Correlation of laboratory and clinical data during treatment of leprosy.
Pattyn SR; Rollier R; Rollier MR; De Muynck A; Janssens PG; Verdoolaeghe-Van Loo G
Ann Soc Belg Med Trop; 1972; 52(6):537-48. PubMed ID: 4574223
[No Abstract] [Full Text] [Related]
32. The activity of rifabutin against Mycobacterium leprae.
Yoder LJ; Jacobson RR; Hastings RC
Lepr Rev; 1991 Sep; 62(3):280-7. PubMed ID: 1665534
[TBL] [Abstract][Full Text] [Related]
33. Rifampicin resistant leprosy: a review and a research proposal of a pilot study.
Ji B
Lepr Rev; 2002 Mar; 73(1):2-8. PubMed ID: 11969122
[No Abstract] [Full Text] [Related]
34. Concepts behind the development of multiple drug therapy regimens in leprosy.
Waters MF
Ethiop Med J; 1986 Dec; 24 Suppl 1():61-7. PubMed ID: 3301333
[No Abstract] [Full Text] [Related]
35. New developments in the chemotherapy of leprosy.
Freerksen E
Lepr India; 1983 Jan; 55(1):122-32. PubMed ID: 6348410
[No Abstract] [Full Text] [Related]
36. The activity of chaulmoogra acids against Mycobacterium leprae.
Levy L
Am Rev Respir Dis; 1975 May; 111(5):703-5. PubMed ID: 1093460
[TBL] [Abstract][Full Text] [Related]
37. Comparison of single daily dose of methimazole and propylthiouracil in the treatment of Graves' hyperthyroidism.
He CT; Hsieh AT; Pei D; Hung YJ; Wu LY; Yang TC; Lian WC; Huang WS; Kuo SW
Clin Endocrinol (Oxf); 2004 Jun; 60(6):676-81. PubMed ID: 15163329
[TBL] [Abstract][Full Text] [Related]
38. A Mycobacterium leprae isolate resistant to dapsone, rifampin, ofloxacin and sparfloxacin.
Matsuoka M; Kashiwabara Y; Namisato M
Int J Lepr Other Mycobact Dis; 2000 Dec; 68(4):452-5. PubMed ID: 11332288
[TBL] [Abstract][Full Text] [Related]
39. Clinical pharmacokinetics of antithyroid drugs.
Kampmann JP; Hansen JM
Clin Pharmacokinet; 1981; 6(6):401-28. PubMed ID: 6172233
[TBL] [Abstract][Full Text] [Related]
40. Drug resistance and multi-drug therapy in leprosy.
Chatterjee BR
Lepr India; 1982 Jul; 54(3):402-11. PubMed ID: 6757576
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
